NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

Conditions

Bones and Joints | Brain and Nervous System | Leukemia, not otherwise specified | Leukemia, other | Lymphoid Leukemia

Phase II

What is the purpose of this trial?

This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.

  • Trial with
    Children's Oncology Group (The)
  • Start Date
    06/17/2018
  • End Date
    12/30/2021

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Regan Pulaski

  • Last Updated
    06/22/2018
  • Study HIC
    #2000022902